Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
about
A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparumA murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytesFurther improvements of the P. falciparum humanized mouse modelAnalysis of innate defences against Plasmodium falciparum in immunodeficient mice.Clodronate liposomes: perspectives in research and therapeutics.De Novo Generated Human Red Blood Cells in Humanized Mice Support Plasmodium falciparum Infection.Antimalarial drug discovery: efficacy models for compound screening.Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicityHuman IDO-competent, long-lived immunoregulatory dendritic cells induced by intracellular pathogen, and their fate in humanized miceNovel approaches in antimalarial drug discovery.Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery.Myocardial Dysfunction: A Primary Cause of Death Due To Severe Malaria in A Plasmodium falciparum-Infected Humanized Mouse ModelSubstrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery.Humanized mouse models infected with human Plasmodium species for antimalarial drug discovery.Plasmodium falciparum Liver Stage Infection and Transition to Stable Blood Stage Infection in Liver-Humanized and Blood-Humanized FRGN KO Mice Enables Testing of Blood Stage Inhibitory Antibodies (Reticulocyte-Binding Protein Homolog 5) In Vivo.
P2860
Q24814432-1D64A1FB-AA6A-48D1-ACD9-476FEF6D974DQ28472751-E7700688-0FE7-4DBB-A1D5-0B641754942BQ28477591-FB1258B9-A440-4786-AA64-6497D2E73352Q34036514-A7717EDF-4711-4417-BC48-F017C1786A82Q35072781-E25A6C80-4FD9-48CF-9CBE-799FEAFF003DQ35670876-8C616647-4D47-4B01-A5DA-097888E252DBQ35790381-94253C37-1042-4D5D-8AAC-53525ECAA206Q37255996-6D72B246-6BF8-4ED0-9062-35D3D6275CCDQ37642581-48179C1C-F9ED-44AC-B17B-41BC131C3A22Q38148787-81EA23EF-3E85-45BE-939C-A66D3C9C17A6Q38537814-6CADBFC8-D214-4646-9048-7EAE4EADD38DQ41680247-27486257-1CA5-45E4-A281-D098F6C2A5A6Q43245922-72B65F42-1B95-4C44-BED6-729B31A0477AQ46252657-F59B0285-7957-44C5-B720-105D8B09592FQ55050933-9B834A99-2A8E-4045-B132-897C9FEB0750
P2860
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
@ast
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
@en
type
label
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
@ast
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
@en
prefLabel
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
@ast
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
@en
P2093
P2860
P1476
Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.
@en
P2093
P2860
P304
P356
10.1128/AAC.45.6.1847-1853.2001
P407
P577
2001-06-01T00:00:00Z